- Home
- IMCR vs WABC Comparison
IMCR vs WABC Comparison
Compare IMCR & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- WABC
- Stock Information
- Founded
- IMCR 2008
- WABC 1972
- Country
- IMCR United Kingdom
- WABC United States
- Employees
- IMCR N/A
- WABC N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- WABC Major Banks
- Sector
- IMCR Health Care
- WABC Finance
- Exchange
- IMCR Nasdaq
- WABC Nasdaq
- Market Cap
- IMCR 1.4B
- WABC 1.3B
- IPO Year
- IMCR 2021
- WABC N/A
- Fundamental
- Price
- IMCR $30.16
- WABC $48.13
- Analyst Decision
- IMCR Buy
- WABC Hold
- Analyst Count
- IMCR 12
- WABC 3
- Target Price
- IMCR $60.90
- WABC $52.50
- AVG Volume (30 Days)
- IMCR 378.9K
- WABC 217.8K
- Earning Date
- IMCR 05-07-2025
- WABC 04-17-2025
- Dividend Yield
- IMCR N/A
- WABC 3.65%
- EPS Growth
- IMCR N/A
- WABC N/A
- EPS
- IMCR N/A
- WABC 4.99
- Revenue
- IMCR $310,202,000.00
- WABC $284,570,000.00
- Revenue This Year
- IMCR $20.52
- WABC N/A
- Revenue Next Year
- IMCR $8.57
- WABC N/A
- P/E Ratio
- IMCR N/A
- WABC $9.66
- Revenue Growth
- IMCR 24.36
- WABC N/A
- 52 Week Low
- IMCR $23.15
- WABC $42.00
- 52 Week High
- IMCR $62.74
- WABC $59.97
- Technical
- Relative Strength Index (RSI)
- IMCR 59.11
- WABC 52.06
- Support Level
- IMCR $27.55
- WABC $47.26
- Resistance Level
- IMCR $30.85
- WABC $48.70
- Average True Range (ATR)
- IMCR 1.95
- WABC 1.84
- MACD
- IMCR 0.44
- WABC 0.45
- Stochastic Oscillator
- IMCR 89.02
- WABC 89.70
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About WABC Westamerica Bancorporation
Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California, and all the way east to Nevada County.